Clinical Trials Logo

Spondylitis clinical trials

View clinical trials related to Spondylitis.

Filter by:

NCT ID: NCT05942976 Completed - Clinical trials for Rheumatoid Arthritis

Enthesis Differences in Rheumatoid Arthritis and Axial Spondyloarthropathy

Start date: June 16, 2023
Phase:
Study type: Observational [Patient Registry]

The aim of this study is to investigate the sonographic differences in entheses in patients with Rheumatoid arthritis and Axial Spondyloarthropathy.

NCT ID: NCT05914532 Completed - Clinical trials for Axial Spondyloarthritis

New Biomarkers in Axial Sypondyloarthropathy; SII and SIRI

Start date: June 22, 2023
Phase:
Study type: Observational

investigators aimed to evaluate the relationship between Systemic Immune Inflammation Index (SII) and Systemic Inflammation Response Index (SIRI) and disease activity in patients with axial spondyloarthropathy (SpA).

NCT ID: NCT05839925 Completed - Clinical trials for Ankylosing Spondylitis

Prevalence of Temporomandibular Joint Dysfunction in Patients With Ankylosing Spondylitis

Start date: April 1, 2022
Phase:
Study type: Observational

This study included 113 patients diagnosed with ankylosing spondylitis and 110 healthy volunteers. Participants in both groups were evaluated using the 'Diagnostic Criteria for Temporomandibular Disorders (DC/TMD)' diagnostic criteria. In addition, the relationship between temporomandibular joint dysfunction and disease activity was investigated in patients with ankylosing spondylitis.

NCT ID: NCT05771389 Completed - Psoriatic Arthritis Clinical Trials

RAFTLIN-1 Levels in Axial Spondyloarthritis and Psoriatic Arthritis

Start date: March 21, 2023
Phase: N/A
Study type: Interventional

Unlike other rheumatic diseases, acute phase reactants such as C-reactive protein and erythrocyte sedimentation rate are not diagnostic for patients with Spondyloarthropathies (SpA). Also, it is not possible to monitor disease activity with these tests. On the other hand, HLA-B27 positivity varies between races, and 8% of the normal population is HLA-B27 positive. In this manner, new biomarkers for endorsing the diagnosis and monitoring the disease activity are necessary. Acute phase reactants are not sensitive for diagnosing and assessing disease activity. This may lead to a diagnostic delay of up to 9 years. The investigators hypothesize that Raftlin-1, thought to have a regulatory role in TH17 function and IL-17-mediated immunity, may be a novel biomarker for showing inflammation-related clinical features.

NCT ID: NCT05771376 Completed - Clinical trials for Ankylosing Spondylitis

The Effects of Baduanjin Qigong Exercise on Ankylosing Spondylitis: A Randomized Controlled Study

Start date: February 13, 2022
Phase: N/A
Study type: Interventional

The aim of this study is to examine the effectiveness of 12-week Baduanjin qigong exercises in patients with ankylosing spondylitis. 59 volunteer individuals, ages 18-64, will be included in the study. They will be randomly divided into two groups (the intervention and the control). The intervention group will perform a qigong exercise program online (via Zoom video conference) for 12 weeks under the supervision of two physiotherapists. The qigong exercise program had previously been videotaped by the researchers. The control group will perform the home exercise program at home for 12 weeks.

NCT ID: NCT05731635 Completed - Clinical trials for Device is Used for Evalution (Event)

Plantar Pressure Values in Patients With Ankylosing Spondylitis

Start date: December 1, 2011
Phase:
Study type: Observational [Patient Registry]

this study was discovered that clinical and radiological characteristics were related to plantar pressure assessments in patients with AS.

NCT ID: NCT05677542 Completed - Psoriatic Arthritis Clinical Trials

Secukinumab (Cosentyx®) Effectiveness in Axial Spondyloarthritis and Psoriatic Arthritis Patients Using Artificial Intelligence (SpAINET): Spanish Multicenter, Retrospective, Real World Evidence Study

Start date: June 2, 2021
Phase:
Study type: Observational

This was a multicenter, retrospective, and non-interventional study using secondary data captured in the Electronic Health Records (EHRs). The extraction of the data captured in the EHRs was performed with EHRead® by SAVANA, an innovating data-driven system based on Natural Language Processing (NLP) and big data analytics. Data was extracted and analyzed at Index Date, Follow Up, or as specified for each variable.

NCT ID: NCT05666115 Completed - Arthritis Clinical Trials

Efficacy of Modification of Lifestyle in the Treatment of Ankylosing Spondylitis: a Pilot Study

EMLAS
Start date: January 2, 2023
Phase: N/A
Study type: Interventional

Axial spondyloarthritis (axSpA) is a chronic inflammatory immune disorder with a global prevalence that ranges from 20 to 160 cases per 10000 individuals. axSpA has two forms of clinical presentation (radiographic and non-radiographic) based on the presence or absence of radiographic sacroiliitis. This condition mostly affects the vertebral spine, and is characterized by joint pain and stiffness, fatigue, and restricted function, which leads to a substantial physical, psychological, and socioeconomic burden. The clinical management of axSpA needs to combine pharmacological and non-pharmacological approaches to reduce inflammation and improve health-related quality of life. The aim of the study will be to determine if a 12-week probiotic supplementation will be more effective than an online-delivered strength training program at improving functional capacity in adults with non-radiographic axSpA. As a secondary aim, we will compare the impact of both interventions on disease activity, spinal mobility, quality of life and biochemical measures. This will be the first randomized controlled trial where probiotics are compared with an active intervention.

NCT ID: NCT05589922 Completed - Clinical trials for Ankylosing Spondylitis

The Relationship Between Abnormal Modified Schober Index and Demographic Characteristics and Clinical Variables

Start date: October 24, 2022
Phase:
Study type: Observational

This study will aim to compare ankylosing spondylitis (AS) participants with abnormal modified Schober index (AMSI) versus AS participants with normal modified Schober index (NMSI) in pain, morning stiffness, balance, kinesiophobia and the fear of falling. In addition, the investigators will aim to determine which demographic characteristics and variables predispose AMSI to occur

NCT ID: NCT05570656 Completed - Clinical trials for Ankylosing Spondylitis

Modeling Spinal Mobility in Ankylosing Spondylitis: Towards New Telekinetic Biomarkers

TELESPA
Start date: December 13, 2022
Phase: N/A
Study type: Interventional

Ankylosing spondylitis (AS) is a chronic inflammatory rheumatic disease that mainly affects the spine and pelvis in its axial form. It is responsible for chronic inflammatory pain and sometimes ankylosis with significant functional retention. Clinicians need markers capable of precisely measuring the restriction of range of motion in these patients, reflections of the activity and/or sequelae of the disease. The Inverstigators validated movement markers in the AS by a device including inertial sensors (XSENS) and computer modeling. The accuracy and repeatability of the XSENS-Awinda system compared to the reference measurement system have been demonstrated. The XSENS-Awinda device offers new real-time evaluation possibilities for quantitative gait analysis. This opens the way to new diagnostic tools, prognostics and therapeutic perspectives for the clinician.